In mice fed with GF-EPS, CD4+ and CD8+ T cells were found to transfer tumor-inhibitory activity to C26-bearing mice, suggesting the ability to modulate an immune response plays a crucial role in the anticancer activity of GF-EPS [22]. The gene discussed is CD4; the disease is neoplasm.